'Cochlear implant for blindness' debuts in Europe, could launch in U.S. in 2027
22 July 2026 · filed under 9d7eb2566898
Science Corporation has announced the European launch of a retinal implant designed for patients with age-related macular degeneration, according to STAT News. The device has been described, in coverage cited by the outlet, as a “cochlear implant for blindness,” drawing a comparison to the auditory device by way of its function as a sensory prosthetic rather than a corrective lens or surgical repair.
STAT News reports the implant could reach the United States market in 2027. The announcement marks the product’s European debut, per the company’s statement as relayed by the outlet.
No further technical detail, patient outcome data, or regulatory specifics accompanied the announcement as summarized. STAT News’s report is behind a paywall (the piece is marked STAT+), and the available material consists of the headline, the original title, and a brief summary rather than the full article text.
The Specola’s log records the report as circulated. Additional particulars, including trial results, mechanism of action, and the regulatory pathway in either market, were not present in the source material provided and are not stated here.
This entry will be updated as fuller reporting becomes available through the observatory’s channels.